SES Logo

SYSTEMIC ENZYME SUPPORT.org

 

Gout

Gout is a form of arthritis that affects mostly middle-aged men and postmenopausal women. After 3 weeks of adding Wobenzym® to conventional gout therapy, they saw an improvement of 94.1% compared to only 47.3% with only conventional therapy.
So when you look at the research, you could say that Wobenzym is a good therapy for all forms of arthritis including osteoarthritis, rheumatoid arthritis, as well as psoriatic arthritis, juvenile chronic arthritis and even gouty arthritis.
                                 From FREQUENTLY ASKED QUESTIONS, with answers by Joseph J Collins, RN, ND
                                 Read the special section:
JOINT PAIN & WOBENZYM®

What the literature says about Systemic Enzyme Support and:

Gout

Systemic enzyme therapy in the gout treatment  

Kovalenko V.N., Siniatchenko O.V., Ignatchenko G.A., Terzov A.I., Grin V.K., Lauschkina E.M.Systemic enzyme therapy in the gout treatment. Ukrainskii kardiologitschnyi zurnal 1998: 1, 53-56.  

36 male patients suffering from primary gout were observed. Patients received non-steroidal antiinflammatory drugs (diclofenac sodium, movalis, phelden, indomethacin) and allopurinol (milurit).
Patients were randomly divided into two groups:
 
19 patients, aged 28-69 years (mean 48.9)
 
17 patients, aged 29-71 (mean 50.2)

Patients in the second group received Wobenzym (5 dragees 3 times a day for 1 week, then 4x3 dragees for 7 days, and finally 3x3 dragees for 1 month) in the complex therapy.
Before therapy and after 3 weeks, purine parameters were determined in the blood – uric acid, oxypurinol, xanthine oxidase, 5-nucleotidase, adenosine deaminase, glycine, glutamine, and aspartic acid.
The efficacy of articular syndrome treatment in patients receiving Wobenzym reached 94.1% in comparison to 47.3% in the control group. Even more obvious were differences regarding renal syndrome.
While the conventional gout treatment led to the decrease of only uric acid and xanthine oxidase in the blood, inclusion of Wobenzym into the therapy caused decrease of oxypurinol, 5-nucleotidase and adenosine deaminase level. Of special interest are data concerning the investigation of serum dynamic interphase tensometry before and after treatment of patients in both groups. Administration of allopurinol and non-steroidal antiinflammatory drugs evoked a suppression of surface tension in the region of short, middle, and long surface life-time. This might be caused by the accumulation of substances with surfactant properties.
Poster Reference Number 77.